血液制品

  • 网络Blood Products;Blood production;Products from the blood
血液制品血液制品
  1. 目前所有血液制品均经过热处理,以防止各种感染。

    All blood products are now heat treated to kill off any infection .

  2. 献血员血清和血液制品的HIV抗体检测及试验方法的优选

    Selection of Methods for HIV Screening of Donors ' Sera and Blood Products

  3. 全血与血液制品中HCVRNA检测及其基因分型的初步研究

    A preliminary study on detection of HCV RNA and HCV RNA subtypes in whole

  4. 血液制品及实验室试剂HBsAg污染的调查研究

    Contamination of HBsAg in the Blood Products and Laboratory Reagents in China

  5. 医院用血液制品HCV污染情况的调查

    Investigation on HCV contamination of blood products in hospitals

  6. 采用~(137)CSγ射线辐照灭活红细胞血液制品中大肠杆菌的实验研究

    ~ ( 137 ) Cs gamma irradiation for sterilization of red blood cells contaminated by escherichia Coli

  7. 随着感染范围的扩大,在HIV阳性的儿童和接受血液制品的HIV感染者也会出现口腔表征。

    With the expansion of infection in HIV-positive children and to accept blood products infected with HIV will also be characterized mouth .

  8. 血液制品原料血浆HBsAg抗-HCV检测结果及分析

    Results and analysis of the HBsAg and Anti-HCV tests of raw plasma to be used for blood products

  9. 结论:LEH是一种低毒性、低免疫原性血液制品。

    Conclusion : LEH was a low toxic and low immunogenic blood substitute .

  10. 目的了解1993~1995年度临床使用的新鲜冰冻血浆(FFP)和血液制品中艾滋病毒(HIV)、丙肝病毒(HCV)的感染情况。

    OBJECTIVE To evaluate the risk of HCV and HIV infection from fresh frozen plasma ( FFP ) and plasma derivatives used in clinical during 1993 ~ 1995 were studied .

  11. Sindbis病毒蚀斑方法的建立及其在血液制品病毒灭活实验中的应用

    Establishment of Plaque Assay for Sindbis Virus and its Application in Study of Virus Inactivation for Blood Products

  12. 因此,加强原料血浆病毒的检测,对提高血液制品的质量,防止临床上输血后肝炎(PTH)的发生至关重要。

    That shows it is highly important to detect virus in plasma to ensure the quality of blood products and to prevent hepatitis ( PTH ) after blood transfusion .

  13. 结论60Coγ射线照射血液制品输注在有效预防输血相关性移植物抗宿主病的同时也能有效减少非溶血性发热输血反应的发生。

    Conclusion ~ 60 Co - irradiated blood can not only prevent transfusion associated graft-versus-host disease ( TA-GVHD ), but also decrease non-hemolytic febrile transfusion reactions ( NHFTR ) effectively .

  14. 结论本研究数据提示吉林省地区献血人员B19病毒感染率较高,有必要进行进一步B19DNA的调查研究,为输血安全和血液制品安全提供保障。

    Conclusion These data illustrate that the prevalence of the B19 antibody in blood donors of Jilin province was high , and it is therefore necessary to detect the B19 DNA to ensure the blood safety .

  15. 血液制品生产分布式网络监控系统的研制

    Research on the Distributed Network Monitoring System in Blood Products Production

  16. 对血液制品S/D病毒灭活方法的验证

    Verification of Virus Inactivation in Blood Products by S / D Method

  17. 某血液制品厂房净化空调设计

    Clean air conditioning design of a blood products factory building

  18. 支持疗法包括使用抗生素和血液制品。

    Supportive therapy includes use of antibiotics and administration of blood products .

  19. 人血红蛋白提纯、改造制备人工血液制品的研究

    Study on Human Purified Hemoglobin and Available Artificial Blood Products

  20. 模型病毒在光化学灭活血液制品中病毒中的应用

    Use of model viruses in the photochemical inactivation of virus in blood products

  21. 频繁需要输血或血液制品的人;

    Persons who frequently require blood or blood products ;

  22. 血站如何进行临床血液制品质控的质量管理模式探讨

    The Modes of the Management in Blood Bank for Quality Control the Blood Supply

  23. 目的建立血液制品生产过程中乙醇含量的测定方法。

    Objective To determinate the method for detection ethanol content in the processing of blood ` preparation .

  24. 血液制品的包装

    Package for blood products

  25. 血液制品生产单位应当在原料血浆投料生产前对每一份血浆进行艾滋病检测;

    The production entity of blood shall carry out HIV testing on plasma before putting the material plasma into production ;

  26. 在2010年5月,世卫组织会员国通过了关于血液制品可得性、安全性和质量的一项决议。

    In May2010 , WHO Member States agreed on a resolution on the availability , safety and quality of blood products .

  27. ·2月7日中国报道`一例13岁的中国血友病患者因使用进口的血液制品而感染艾滋病死亡。今年2月底,加拿大的一个染上艾滋病病毒和丙型肝炎的血友病患者团体突然造访华盛顿。

    At the end of February , a group of Canadian haemophiliacs infected with HIV and hepatitis C descended on Washington .

  28. 该决议为在发展中国家加强获取安全输血以及安全和负担得起的血液制品铺平了道路。

    The resolution paves the way to increase access to safe blood transfusions and to safe and affordable blood products in developing countries .

  29. 目的通过检测一次性采血器材和注射用液体制剂的细菌内毒素含量,杜绝不合格产品进入血站,为医疗用血机构提供安全、合格的血液制品。

    Objective To measure bacterial endotoxin of blood-collection material and injective liquid preparation so as to provide safe and qualified blood products for hospitals .

  30. 那时,比尔·克林顿正是阿肯色州的州长,而食品和药物管理局已经做出过裁定,说采自监狱的血浆不安全,不宜用于国内生产血液制品。

    FDA had already ruled that prison plasma was too unsafe to be used for the manufacture of blood products inside the United States .